150 related articles for article (PubMed ID: 28157704)
1. Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression.
Han B; Shen Y; Zhang P; Jayabal P; Che R; Zhang J; Yu H; Fei P
Oncotarget; 2017 Apr; 8(14):22490-22500. PubMed ID: 28157704
[TBL] [Abstract][Full Text] [Related]
2. BLM promotes the activation of Fanconi Anemia signaling pathway.
Panneerselvam J; Wang H; Zhang J; Che R; Yu H; Fei P
Oncotarget; 2016 May; 7(22):32351-61. PubMed ID: 27083049
[TBL] [Abstract][Full Text] [Related]
3. Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors.
Moriel-Carretero M; Ovejero S; Gérus-Durand M; Vryzas D; Constantinou A
J Cell Biol; 2017 Dec; 216(12):4007-4026. PubMed ID: 29030393
[TBL] [Abstract][Full Text] [Related]
4. TFG-maintaining stability of overlooked FANCD2 confers early DNA-damage response.
Ma C; Hokutan K; Shen Y; Nepal M; Kim JH; Zhang J; Fei P
Aging (Albany NY); 2020 Oct; 12(20):20268-20284. PubMed ID: 33099537
[TBL] [Abstract][Full Text] [Related]
5. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
6. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
[TBL] [Abstract][Full Text] [Related]
7. FANCD2 and DNA Damage.
Nepal M; Che R; Ma C; Zhang J; Fei P
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825622
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in human tumors.
Xie X; Zhao Y; Du F; Cai B; Fang Z; Liu Y; Sang Y; Ma C; Liu Z; Yu X; Zhang C; Jiang J; Gao Z; Liu Y; Lin X; Jing H; Zhong X; Cong L; Dai H; Sha D; Shao N; Feng H; Li L; Liu J; Shang L
Genomics; 2024 Jan; 116(1):110762. PubMed ID: 38104669
[TBL] [Abstract][Full Text] [Related]
9. The identification of FANCD2 DNA binding domains reveals nuclear localization sequences.
Niraj J; Caron MC; Drapeau K; Bérubé S; Guitton-Sert L; Coulombe Y; Couturier AM; Masson JY
Nucleic Acids Res; 2017 Aug; 45(14):8341-8357. PubMed ID: 28666371
[TBL] [Abstract][Full Text] [Related]
10. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
11. Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid.
Burgos-Morón E; Calderón-Montaño JM; Orta ML; Guillén-Mancina E; Mateos S; López-Lázaro M
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27399778
[TBL] [Abstract][Full Text] [Related]
12. FANCJ protein is important for the stability of FANCD2/FANCI proteins and protects them from proteasome and caspase-3 dependent degradation.
Clark DW; Tripathi K; Dorsman JC; Palle K
Oncotarget; 2015 Oct; 6(30):28816-32. PubMed ID: 26336824
[TBL] [Abstract][Full Text] [Related]
13. Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.
Park HK; Wang H; Zhang J; Datta S; Fei P
PLoS One; 2010 Oct; 5(10):e13313. PubMed ID: 20967207
[TBL] [Abstract][Full Text] [Related]
14. The impact of FANCD2 deficiency on formaldehyde-induced toxicity in human lymphoblastoid cell lines.
Ren X; Ji Z; McHale CM; Yuh J; Bersonda J; Tang M; Smith MT; Zhang L
Arch Toxicol; 2013 Jan; 87(1):189-96. PubMed ID: 22872141
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
16. A hidden role of the inactivated FANCD2: upregulating ΔNp63.
Panneerselvam J; Pickering A; Zhang J; Wang H; Tian H; Zheng J; Fei P
Oncotarget; 2013 Sep; 4(9):1416-26. PubMed ID: 23965832
[TBL] [Abstract][Full Text] [Related]
17. Advances in the understanding of the Fanconi anemia tumor suppressor pathway.
Pickering A; Zhang J; Panneerselvam J; Fei P
Cancer Biol Ther; 2013 Dec; 14(12):1089-91. PubMed ID: 24025411
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
[TBL] [Abstract][Full Text] [Related]
19. FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia.
Pilonetto DV; Pereira NF; Bitencourt MA; Magdalena NI; Vieira ER; Veiga LB; Cavalli IJ; Ribeiro RC; Pasquini R
Braz J Med Biol Res; 2009 Mar; 42(3):237-43. PubMed ID: 19287902
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
